Bioequivalence of combined preparations g to be compulsory

Korean generic makers will have to conduct bioequivalence testing over combined preparations as the Korea Food and Drug Administration intends to evaluate the efficacy and safety of these medicines.

To this end, the KFDA will hold an information session on November 18 to establish a guideline for the bioequivalence testing.

“The plan is to enable the national health insurance to pay for m...